Caxton Associates (UK)’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
113,055
+42,987
+61% +$575K 0.03% 324
2026
Q1
$879K Sell
70,068
-52,762
-43% -$688K 0.02% 406
2025
Q4
$1.53M Buy
122,830
+20,770
+20% +$264K 0.03% 263
2025
Q3
$1.35M Buy
102,060
+11,080
+12% +$154K 0.03% 279
2025
Q2
$1.26M Hold
90,980
0.03% 280
2025
Q1
$1.17M Buy
+90,980
New +$1.28M 0.04% 292

Other funds holding CIM

Caxton Associates (UK)'s CIM Position: Q2 2026 in Review

Caxton Associates (UK) increased its Chimera Investment (CIM) stake by 61% in Q2 2026, buying an estimated $575K and bringing the position to 113,055 shares worth $1.51M. The position accounts for 0.03% of the portfolio, ranked #324.

Caxton Associates (UK) first reported a position in CIM in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.53M in Q4 2025. 198 funds tracked by Wall St. Rank hold CIM as of Q2 2026.

  • Caxton Associates (UK) held 113,055 shares of Chimera Investment worth $1.51M as of Q2 2026.
  • Caxton Associates (UK) bought 42,987 Chimera Investment shares in Q2 2026, an estimated $575K.
  • Chimera Investment made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #324 holding.
  • Caxton Associates (UK) first reported a position in Chimera Investment in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Chimera Investment position peaked at $1.53M in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.